Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology ROA 2010-2025 | POAI

Current and historical return on assets (ROA) values for Predictive Oncology (POAI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Predictive Oncology ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-06-30 $-0.01B $0.00B -171.43%
2025-03-31 $-0.01B $0.01B -137.93%
2024-12-31 $-0.01B $0.01B -141.18%
2024-09-30 $-0.01B $0.01B -120.93%
2024-06-30 $-0.01B $0.01B -96.30%
2024-03-31 $-0.01B $0.01B -87.50%
2023-12-31 $-0.01B $0.01B -66.67%
2023-09-30 $-0.02B $0.02B -80.00%
2023-06-30 $-0.02B $0.02B -72.38%
2023-03-31 $-0.03B $0.03B -83.33%
2022-12-31 $-0.03B $0.03B -74.07%
2022-09-30 $-0.03B $0.03B -65.36%
2022-06-30 $-0.03B $0.04B -60.82%
2022-03-31 $-0.02B $0.04B -39.58%
2021-12-31 $-0.02B $0.04B -41.67%
2021-09-30 $-0.02B $0.05B -57.14%
2021-06-30 $-0.03B $0.06B -74.07%
2021-03-31 $-0.03B $0.04B -99.05%
2020-12-31 $-0.03B $0.01B -120.00%
2020-09-30 $-0.03B $0.03B -121.21%
2020-06-30 $-0.03B $0.03B -101.89%
2020-03-31 $-0.02B $0.03B -79.28%
2019-12-31 $-0.02B $0.02B -87.91%
2019-09-30 $-0.01B $0.03B -49.32%
2019-06-30 $-0.01B $0.03B -69.57%
2019-03-31 $-0.01B $0.01B -244.44%
2018-12-31 $-0.01B $0.00B -210.53%
2018-09-30 $-0.01B $0.01B -168.42%
2018-06-30 $-0.01B $0.00B -141.18%
2018-03-31 $-0.01B $0.01B -155.56%
2017-12-31 $-0.01B $0.00B -141.18%
2017-09-30 $-0.01B $0.00B -150.00%
2017-06-30 $-0.01B $0.01B -160.00%
2017-03-31 $-0.01B $0.01B -184.62%
2016-12-31 $-0.01B $0.00B -233.33%
2016-09-30 $-0.01B $0.00B -213.33%
2016-06-30 $-0.01B $0.00B -152.38%
2016-03-31 $-0.01B $0.00B -126.32%
2015-12-31 $0.00B $0.01B -100.00%
2015-09-30 $0.00B $0.01B -145.45%
2015-06-30 $0.00B $0.00B -400.00%
2015-03-31 $-0.01B $0.00B -500.00%
2014-12-31 $-0.01B $0.00B -700.00%
2014-09-30 $-0.01B $0.00B -700.00%
2014-06-30 $-0.01B $0.00B -1000.00%
2014-03-31 $-0.01B $0.00B -1200.00%
2013-12-31 $-0.01B $0.00B -1200.00%
2013-09-30 $-0.01B $0.00B -1800.00%
2013-06-30 $-0.01B $0.00B -3200.00%
2013-03-31 $-0.01B $0.00B -3600.00%
2012-12-31 $-0.01B $0.00B 0.00%
2012-09-30 $-0.01B $0.00B 0.00%
2012-06-30 $-0.01B $0.00B 0.00%
2012-03-31 $-0.01B $0.00B 0.00%
2011-12-31 $0.00B $0.00B 0.00%
2011-09-30 $0.00B $0.00B 0.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.855B 58.34
Tempus AI (TEM) United States $12.818B 0.00
Doximity (DOCS) United States $12.199B 54.28
Hims & Hers Health (HIMS) United States $10.401B 85.22
IRhythm Technologies (IRTC) United States $5.159B 0.00
Hinge Health (HNGE) United States $4.608B 0.00
Privia Health (PRVA) United States $2.610B 193.36
Inspire Medical Systems (INSP) United States $2.596B 38.16
Heartflow (HTFL) $2.530B 0.00
Phreesia (PHR) United States $1.708B 0.00
Enovis (ENOV) United States $1.689B 8.93
10x Genomics (TXG) United States $1.663B 0.00
Omnicell (OMCL) United States $1.456B 28.04
Schrodinger (SDGR) United States $1.426B 0.00
Azenta (AZTA) United States $1.393B 60.78
Clover Health Investments (CLOV) United States $1.358B 0.00
Claritev (CTEV) United States $1.180B 0.00
Evolent Health (EVH) United States $1.092B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Zepp Health (ZEPP) Netherlands $0.491B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Talkspace (TALK) United States $0.429B 128.00
Carlsmed (CARL) $0.360B 0.00
Butterfly Network (BFLY) United States $0.360B 0.00
TruBridge (TBRG) United States $0.289B 50.74
Outset Medical (OM) United States $0.236B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.193B 0.00
CapsoVision (CV) United States $0.178B 0.00
MDxHealth SA (MDXH) Belgium $0.135B 0.00
American Well (AMWL) United States $0.115B 0.00
CareCloud (CCLD) United States $0.110B 5.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.069B 0.00
Pulmonx (LUNG) United States $0.064B 0.00
111 (YI) China $0.058B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.035B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00